Skip to content

+ 33 (0) 1 55 26 82 16
contact@cardiawave.com
3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search for:

+ 33 (0) 1 55 26 82 16
contact@cardiawave.com
3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

Search for:

Home
About Us
Aortic Stenosis
- Unmet Medical Need
- Current Treatment
Health Professionals
News
- News
- Media Area
Contact

Corporate News

Home
Blog
Corporate News
Page 2

420x300-internal2

AMEL KORSO-FECIANE, TEST BENCH ENGINEER

Feb 2, 2021

Posts navigation

PrevPrevious page Page 1 Page 2

Categories

About Us
Aortic Stenosis
Careers
Clinical Studies
Corporate News
Events
Other news
Press Release
Scientific Publications

l Latest news

Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis.
Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France.

l Our social networks

LinkedIn
Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l December 2nd, 2021

Legal Mentions